Michael Chi Sells 17,303 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS) insider Michael Chi sold 17,303 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $48.14, for a total value of $832,966.42. Following the completion of the transaction, the insider now owns 193,601 shares of the company’s stock, valued at approximately $9,319,952.14. The trade was a 8.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Michael Chi also recently made the following trade(s):

• On Monday, February 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The stock was sold at an average price of $43.28, for a total value of $314,169.52.
• On Friday, January 24th, Michael Chi sold 17,304 shares of Hims & Hers Health stock. The stock was sold at an average price of $31.00, for a total value of $536,424.00.
• On Friday, January 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The stock was sold at an average price of $24.07, for a total value of $174,724.13.
• On Tuesday, December 24th, Michael Chi sold 17,303 shares of Hims & Hers Health stock. The stock was sold at an average price of $27.97, for a total value of $483,964.91.
• On Thursday, December 19th, Michael Chi sold 7,500 shares of Hims & Hers Health stock. The shares were sold at an average price of $26.00, for a total value of $195,000.00.
• On Tuesday, December 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The shares were sold at an average price of $32.25, for a total value of $234,102.75.
• On Monday, December 2nd, Michael Chi sold 2,054 shares of Hims & Hers Health stock. The shares were sold at an average price of $33.56, for a total value of $68,932.24.

Hims & Hers Health Stock Down 22.1 %

HIMS opened at $39.95 on Wednesday. The company has a market cap of $8.73 billion, a price-to-earnings ratio of 90.79 and a beta of 1.35. Hims & Hers Health, Inc. has a 52-week low of $9.67 and a 52-week high of $72.98. The firm’s fifty day simple moving average is $35.62 and its two-hundred day simple moving average is $26.25.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings results on Monday, February 24th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.02. The firm had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. On average, research analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on HIMS shares. Piper Sandler lifted their price target on Hims & Hers Health from $24.00 to $35.00 and gave the company a “neutral” rating in a research report on Tuesday. Citigroup lifted their price target on Hims & Hers Health from $25.00 to $27.00 and gave the company a “sell” rating in a research report on Tuesday. BTIG Research started coverage on Hims & Hers Health in a research report on Tuesday, January 7th. They set a “buy” rating and a $35.00 price target for the company. Leerink Partners lifted their price target on Hims & Hers Health from $24.00 to $40.00 and gave the company a “market perform” rating in a research report on Tuesday. Finally, Bank of America boosted their price objective on Hims & Hers Health from $18.00 to $21.00 and gave the company an “underperform” rating in a research report on Thursday, February 20th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $33.40.

Hedge Funds Weigh In On Hims & Hers Health

Several hedge funds and other institutional investors have recently modified their holdings of HIMS. Creative Planning lifted its stake in shares of Hims & Hers Health by 18.1% in the third quarter. Creative Planning now owns 25,925 shares of the company’s stock worth $478,000 after buying an additional 3,979 shares in the last quarter. International Assets Investment Management LLC purchased a new position in shares of Hims & Hers Health in the third quarter worth about $6,790,000. Dakota Wealth Management purchased a new position in shares of Hims & Hers Health in the third quarter worth about $245,000. Diversify Advisory Services LLC lifted its stake in shares of Hims & Hers Health by 14.9% in the third quarter. Diversify Advisory Services LLC now owns 51,828 shares of the company’s stock worth $955,000 after buying an additional 6,706 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. purchased a new position in shares of Hims & Hers Health in the third quarter worth about $604,000. 63.52% of the stock is owned by hedge funds and other institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.